COSMAX NBT INC.
KKRX:2220404,855.00
KRW
-30.00
(-0.61%)
ISIN
KR7222040008
Return %
Stock
S&P 500
1Y
48.24
14.20
3Y
-7.87
81.12
5Y
-41.36
68.34
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Nam-Joong Kim
- Full Time Employees
- 632
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Seongnam-si South Korea
- IPO Date
- Nov 9, 2015
- Website
- cosmaxnbt.com
- Similar Companies
- Business
- COSMAX NBT INC. is a South Korea-based original design manufacturer (ODM) and original equipment manufacturer (OEM) specializing in the research, development, and manufacturing of health functional foods, dietary supplements, and nutritional solutions. The company develops and manufactures a broad spectrum of nutritional products across diverse dosage delivery formats, including tablets, effervescent forms, and chewables; hard capsules and plant-derived soft capsules; powders, granules, and single-serve stick packs; liquid ampoules, tonics, and functional beverages; and confectionery-style health gummies and jellies. Its systematic product portfolio covers a wide array of health categories, including immune enhancement and red ginseng formulations; probiotics, prebiotics, and gut microbiome solutions; multivitamins, minerals, and essential micronutrients; cardiovascular, lipid, and omega-3 formulations; eye health complexes containing lutein and astaxanthin; bone and joint health products utilizing MSM, glucosamine, and calcium complexes; liver protection and vitality supplements powered by milk thistle; metabolic support and weight management formulations; and inner-beauty nutritional products enriched with collagen peptides, hyaluronic acid, and elastin. In addition to finished product manufacturing, COSMAX NBT INC. offers full-service turnkey ODM and OEM capabilities, encompassing proprietary functional ingredient discovery; clinical research and trial support; domestic and international regulatory compliance and registration; customized recipe and flavor engineering; container and blister packaging design; and stringent quality assurance certified under South Korean MFDS cGMP, US FDA cGMP, NSF International, and Australian TGA standards. Founded in 2002 and headquartered in Seongnam-si, Gyeonggi-do, South Korea, COSMAX NBT INC. operates as a core subsidiary of the COSMAX Group, maintaining integrated manufacturing and sales networks across South Korea, the United States, Australia, and China to serve consumer healthcare brands, pharmaceutical companies, direct-selling enterprises, and retail distributors worldwide. In recent operations, COSMAX NBT INC. has advanced its global manufacturing infrastructure by expanding high-demand alternative dosage lines, notably scaling gummy and dual-formulation liquid-tablet packaging capacities across its production facilities in the United States and Australia. The company has also accelerated the development and commercialization of patented, individually approved functional raw materials recognized for joint support, metabolic health, and skin barrier improvement. Furthermore, COSMAX NBT INC. has expanded into the personalized nutrition market through customized small-batch packaging and digital health partnerships under regulatory sandbox initiatives, while strengthening strategic supply agreements with global health and wellness brands across North America, Southeast Asia, and East Asia.